Genetic analysis can improve depression therapyJanuary 12, 2018
The failure of drugs such as SSRIs, used to treat depression, can be a result of genetic variations in patients. Variations within the gene that encodes the CYP2C19 enzyme results in extreme differences in the levels of escitalopram achieved in patients, according to a new study published in The American Journal of Psychiatry. Prescribing the dose of escitalopram based on a patient's specific genetic constitution would greatly improve therapeutic outcomes. The study was conducted at Karolinska Institutet in Sweden in association with researchers at Diakonhjemmet Hospital in Oslo, Norway.
Pharmaceutical treatment of depression commonly makes use of selective serotonin reuptake inhibitors (SSRIs) of which escitalopram is the most frequently administered clinically. However, escitalopram therapy is currently limited by the fact that some patients do not respond well to the drug, while others develop adverse reactions requiring discontinuation of treatment.
In order to individualise drug therapy, researchers are attempting to establish genetic biomarkers that can predict an individual's response to drugs. In a recent study, it was discovered that variation in the gene encoding the enzyme responsible for escitalopram metabolism (CYP2C19) is very important in this respect. Individuals with a variant of the gene promoting increased enzyme expression had blood levels of escitalopram too low to impact the depression symptoms, whereas patients with a defective CYP2C19 gene reached drug levels which were too high. Overall, one third of the 2,087 study participants achieved escitalopram blood levels that were either too high or too low.
Interestingly, the researchers found that 30 per cent of the patients carrying gene variants causing excessive or inadequate enzyme levels switched to other drugs within one year, in contrast with only 10 to 12 per cent of patients carrying the common gene.
"Our study shows that genotyping of CYP2C19 could be of considerable clinical value in individualising doses of escitalopram so that a better all-round antidepressive effect could be achieved for the patients," says Professor Magnus Ingelman-Sundberg at Karolinska Institutet's Department of Physiology and Pharmacology who led the study together with Professor Espen Molden. "Because CYP2C19 is involved in the metabolism of many different SSRIs, the finding is also applicable to other types of antidepressants."
The study was financed with grants from the Swedish Brain Fund, the Swedish Research Council and Horizon 2020 (the EU framework programme for research and innovation). Co-author Espen Molden has declared a fee from the company Lundbeck for running psychopharmacology courses for doctors; the other authors have reported no commercial interests.
Related Drugs Articles:
Thousands of drugs have the potential to be effective against other diseases than they were developed for.
systemsDock is a new, free on-line resource that makes screening for drugs faster and more accurate.
New research shows that more migraines could be safely treated with drugs that are known to constrict blood vessels.
A major reason why cancer drugs fail is that they cannot penetrate the high-pressure environment of solid tumors.
A new strategy for engineering protein fusions -- to make specific cell-targeted drugs without side effects -- could enable a safer, more potent class of protein drugs.
Synthetic drugs such as 'bath salts,' 'K2' or 'Spice' have made unsettling headlines lately, with reports of violent, erratic behavior and deaths after people have used the substances.
A group of drugs already in everyday use to treat psychosis or depression may also be used to defeat deadly and emerging viruses, according to new research led by the University of Leeds.
What is the mechanism of action of metal-based chemotherapy drugs (the most widely used for treating common cancers like testicular or ovarian cancer)?
The use of superlatives to describe cancer drugs in news articles as 'breakthrough,' 'revolutionary,' 'miracle' or in other grandiose terms was common even when drugs were not yet approved, had no clinical data or not yet shown overall survival benefits, according to an article published online by JAMA Oncology.
With a three-year, $346,000 award from the National Institutes of Health, a research team at Worcester Polytechnic Institute.
Related Drugs Reading:
Buzzed: The Straight Facts About the Most Used and Abused Drugs from Alcohol to Ecstasy (Fully Revised and Updated Fourth Edition)
by Cynthia Kuhn Ph.D. (Author), Scott Swartzwelder Ph.D. (Author), Wilkie Wilson Ph.D. (Author), Jeremy Foster (Foreword), Leigh Heather Wilson (Foreword)
The fourth edition of the essential, accessible source for understanding how drugs work and their effects on body and behavior.A bestseller in its three previous editions, Buzzed is now revised and updated with the most recent discoveries about drugs. It includes new information about biological and behavioral changes in addiction, the prescription-drug abuse epidemic, distinctive drug effects on the adolescent brain, and trends from synthetic cannabinoids to e-cigarettes. “Lively, highly informative, unbiased, [and] thorough” (Addiction Research &... View Details
Davis's Drug Guide for Nurses
by April Hazard Vallerand PhD RN FAAN (Author), Cynthia A. Sanoski BS PharmD FCCP BCPS (Author)
Davis’s Drug Guide for Nurses®, Fifteenth Edition delivers all of the information you need to administer medications safely across the lifespan—well-organized monographs for hundreds of generic and thousands of trade-name drugs.
FREE DIGITAL ACCESS
New information on the National Cancer Institute's "Common Terminology Criteria for Adverse Events" classification systemNew appendices: Understanding biosimilar drugsSafe disposal of unused drugs: What patients need to knowPrescription drug abuse: Identifying and treating toxicityPregnancy-Lactation-Reproduction information highlighted in every... View Details
Drug Muggers: Which Medications Are Robbing Your Body of Essential Nutrients--and Natural Ways to Restore Them
by Suzy Cohen RPh (Author)
Unpleasant, uncomfortable, and unexplained side effects? Drug Muggers is your side effect solution.
Prescription and over-the-counter drugs help millions of people with devastat-ing diseases and chronic conditions. But in the process, these medications can also deplete the body's natural stores of vitamins, minerals, and hormones―the very nutrients you need to keep energy levels high, fend off infections, and be healthy. Pharmacist Suzy Cohen calls these medications "drug muggers," and she says it's essential to replenish what a drug mugger steals from your body in order to feel... View Details
Drugs, Society, and Human Behavior
by Carl L Hart Dr. (Author), Charles J. Ksir (Author)
Drugs, Society and Human Behavior provides the latest information on drug use and its effects on society as well as on the individual. Trusted for more than 40 years by both instructors and students, this authoritative resource examines drugs and drug use from a variety of perspectives―behavioral, pharmacological, historical, social, legal, and clinical. The 16th edition includes the very latest information and statistics and many new timely topics and issues have been added that are sure to pique students’ interest and stimulate class discussion.
Instructors and students... View Details
Narconomics: How to Run a Drug Cartel
by Tom Wainwright (Author)
What drug lords learned from big business
How does a budding cartel boss succeed (and survive) in the $300 billion illegal drug business? By learning from the best, of course. From creating brand value to fine-tuning customer service, the folks running cartels have been attentive students of the strategy and tactics used by corporations such as Walmart, McDonald's, and Coca-Cola.
And what can government learn to combat this scourge? By analyzing the cartels as companies, law enforcers might better understand how they work—and stop throwing away $100... View Details
Drugs: From Discovery to Approval
by Rick Ng (Author)
The third edition of this best-selling book continues to offer a user-friendly, step-by-step introduction to all the key processes involved in bringing a drug to the market, including the performance of pre-clinical studies, the conduct of human clinical trials, regulatory controls, and even the manufacturing processes for pharmaceutical products.Concise and easy to read, Drugs: From Discovery to Approval, Third Edition quickly introduces basic concepts, then moves on to discuss target selection and the drug discovery process for both small and large molecular drugs. The... View Details
Chefs, Drugs and Rock & Roll: How Food Lovers, Free Spirits, Misfits and Wanderers Created a New American Profession
by Andrew Friedman (Author)
An all-access history of the evolution of the American restaurant chef
Chefs, Drugs and Rock & Roll transports readers back in time to witness the remarkable evolution of the American restaurant chef in the 1970s and '80s. Taking a rare, coast-to-coast perspective, Andrew Friedman goes inside Chez Panisse and other Bay Area restaurants to show how the politically charged backdrop of Berkeley helped draw new talent to the profession; into the historically underrated community of Los Angeles chefs, including a young Wolfgang Puck and future stars such as Susan... View Details
2018 Lippincott Pocket Drug Guide for Nurses
by Amy M. Karch MSN RN (Author)
The 2018 Lippincott Pocket Drug Guide for Nurses provides current, vital drug information “in a nutshell.” Based on the popular Lippincott Nursing Drug Guide by Amy Karch, this handy pocket guide by the same author gives essential information on over 2,000 medications in an easy-access A-to-Z format. The “mini” drug monographs include generic and trade names, drug class, pregnancy risk category and controlled substance schedule, “black box” warnings, indications & dosages, dose adjustments, adverse effects, drug interactions, nursing considerations, and... View Details